Gasporox AB (GPX) AI Stock Analysis

• Market Cap: kr71.83M
• Dividend Yield: N/A
• Average Volume (3M): 8.42K
• Price to Earnings (P/E): ―
• Beta (1Y): -0.05
• Revenue Growth: -18.18%
• EPS Growth: -415.63%
• Country: SE
• Employees: 20
• Sector: Technology
• Sector Strength: 87
• Industry: Hardware, Equipment & Parts
• EPS (TTM): -0.41
• Shares Outstanding: 9,353,246
• 10 Day Avg. Volume: 5,003
• 30 Day Avg. Volume: 8,420
• PEG Ratio: N/A
• Price to Book (P/B): N/A
• Price to Sales (P/S): N/A
• P/FCF Ratio: N/A
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: kr8.00
• Price Target Upside: 4.17% Upside
• Rating Consensus: Hold
• Number of Analyst Covering: 0

• Rating: 56 Neutral
• Price Target: kr8.00 ▲(4.17% Upside)

Gasporox AB's overall stock score is primarily influenced by its strong financial performance, with robust revenue growth and a stable balance sheet. However, technical indicators suggest bearish momentum, and the negative P/E ratio highlights valuation concerns. The absence of earnings call data and corporate events limits additional insights.

Gasporox AB Business Overview & Revenue Model

Company Description

Gasporox AB (publ) develops and commercializes products based on laser spectroscopy. It offers GasSpect series of sensors for headspace analysis; LeakSpect series of sensors for detecting leaks of carbon dioxide from packages; MicroLab laboratory instruments for research and development of packages and materials; and GPX1500, a non-intrusive oxygen headspace gas analyzer. The company also provides measurement services for package and process evaluations. Gasporox AB (publ) was founded in 2005 and is based in Lund, Sweden.

How the Company Makes Money

Gasporox AB generates revenue through the sale of its gas detection products and systems, alongside associated software solutions that provide data analytics and monitoring capabilities. Key revenue streams include direct product sales to pharmaceutical and food manufacturers, as well as recurring income from service contracts for system maintenance and data management. The company also benefits from strategic partnerships with industry leaders and research institutions, which enhance its product offerings and expand its market reach. Additionally, GPX may engage in collaborative research projects funded by grants or partnerships, contributing to its overall financial performance.

Gasporox AB Financial Statement Overview

Summary

Gasporox AB shows strong revenue growth and effective cost management, leading to a high gross profit margin. The balance sheet is stable with zero debt, but challenges with profitability and declining stockholders' equity pose risks. Improved operating and free cash flows indicate better financial management, despite past capital expenditures impacting cash flow stability.

Income Statement

Gasporox AB has demonstrated a strong revenue growth trend from 2020 to 2024, with a notable increase in total revenue from SEK 12.45 million in 2020 to SEK 34.10 million in 2024. The gross profit margin remains high, showcasing effective cost management. However, the company continues to face challenges with profitability, as indicated by negative EBIT and net profit margins.

Balance Sheet

The company's balance sheet shows strong equity, with a high equity ratio and zero debt in recent years, indicating financial stability. However, declining stockholders' equity over the years may pose a risk. The absence of liabilities is a positive indicator for the company's financial health.

Cash Flow

Gasporox AB has improved its operating cash flow significantly, turning from negative to positive over the years, which indicates better cash management. Free cash flow growth has also been positive in the latest year. However, the significant capital expenditures in prior years have impacted free cash flow negatively.

Breakdown	TTM	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Income Statement
Total Revenue	26.61M	34.10M	31.43M	21.45M	15.74M	12.45M
Gross Profit	26.22M	33.10M	30.69M	22.45M	16.26M	13.16M
EBITDA	-3.97M	-347.00K	946.00K	-3.25M	-4.69M	-3.82M
Net Income	-10.97M	-2.68M	-1.25M	-4.56M	-5.39M	-4.36M
Balance Sheet
Total Assets	51.86M	39.97M	43.52M	44.43M	37.37M	41.14M
Cash, Cash Equivalents and Short-Term Investments	12.31M	6.81M	10.62M	14.56M	14.27M	24.23M
Total Debt	14.07M	2.32M	8.73M	8.43M	0.00	0.00
Total Liabilities	32.65M	13.28M	20.33M	19.99M	8.74M	7.07M
Stockholders Equity	19.21M	26.69M	23.19M	24.44M	28.63M	34.07M
Cash Flow
Free Cash Flow	325.00K	-3.52M	-3.98M	-8.28M	-9.91M	-6.09M
Operating Cash Flow	-2.48M	4.36M	3.34M	-1.19M	-3.39M	-642.00K
Investing Cash Flow	-7.98M	-7.52M	-7.04M	-7.01M	-6.52M	-5.45M
Financing Cash Flow	12.12M	-648.00K	-240.00K	8.50M	-53.00K	18.00M

Gasporox AB Technical Analysis

• Technical Analysis Sentiment: Positive
• Last Price: 7.68
• 50DMA: Negative
• 100DMA: Negative
• 200DMA: Negative
• MACD: Negative
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For SE:GPX, the sentiment is Positive. The current price of 7.68 is above the 20-day moving average (MA) of 7.46, below the 50-day MA of 7.80, and below the 200-day MA of 8.01, indicating a neutral trend. The MACD of -0.20 indicates Negative momentum. The RSI at 51.58 is Neutral, neither overbought nor oversold. The STOCH value of 54.44 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for SE:GPX.

Gasporox AB Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
Sector *	61 Neutral	$35.43B	7.71	-10.08%	1.88%	8.71%	-9.18%
GPX	56 Neutral	kr71.83M	―		―	-18.18%	-415.63%
FGRRF	―	$15.08M	―	-95.82%	―	―	―
0RVF	―	kr281.30M	―	-19.05%	―	―	―
7YV	―	€2.04M	―	-93.20%	―	―	―
2LU	―	€33.45M	―	-10.88%	―	―	―
UNIBAP	―	kr452.33M	56.89		―	―	―